John J. Court

Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2

Michael P. Clark, Mark W. Ledeboer, Ioana Davies et al. · Journal of Medicinal Chemistry · 2014 · 207 citations · Full text

Influenza Pb2, Medicinal Chemistry, Medicine +13

Enantioselective conversion of anthranilic acid derivatives to chiral cyclohexanes. Total synthesis of (+)-pumiliotoxin C

Arthur G. Schultz, Patrick J. McCloskey, John J. Court · Journal of the American Chemical Society · 1987 · 75 citations

Anthranilic Acid Derivatives, Engineering, Biochemistry +14

Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimization

Robert B. Perni, J. PITLIK, Shawn Britt et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 62 citations · Full text

Immunology, Antiviral Drug Development, Hepatitis +9

Inhibitors of hepatitis C virus NS3·4A protease. Part 3: P2 proline variants

Robert B. Perni, Luc J. Farmer, Kevin M. Cottrell et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 52 citations · Full text

Viral Hepatitis, Antiviral Drug Development, Antiviral Therapy +9

Design, Synthesis, and Structure–Activity Relationships of Pyridine-Based Rho Kinase (ROCK) Inhibitors

Jeremy Green, Jingrong Cao, Upul K. Bandarage et al. · Journal of Medicinal Chemistry · 2015 · 51 citations · Full text

Pharmacotherapy, Pyridine-based Rho Kinase, Structure–activity Relationships +18